1. Serum Phosphate and 1-Year Outcome in Patients With Acute Ischemic Stroke and Transient Ischemic Attack
- Author
-
Jun-Fang Zhang, Jing Jing, Xia Meng, Yuesong Pan, Yi-Long Wang, Xing-Quan Zhao, Jin-Xi Lin, Xin-Sheng Han, Bin-Bin Song, Zheng-Chang Jia, Song-Di Wu, Xiao-Fei Chen, Wen-Jun Xue, Craig S. Anderson, Yun-Cheng Wu, and Yong-Jun Wang
- Subjects
serum phosphate ,stroke ,recurrence ,mortality ,outcome ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Objective: To determine the association between serum phosphate level and 1-year clinical outcomes in patients with acute ischemic stroke and transient ischemic attack.Methods: We included 7,353 patients with acute ischemic stroke and transient ischemic attack from the China National Stroke Registry III for analysis. Participants were divided into 4 groups according to serum phosphate quartiles. Composite end point included recurrent stroke, myocardial infarction, other ischemic vascular events, and all-cause mortality. Poor functional outcome is defined as modified Rankin Scale score of 3 to 6. Multivariable Cox regression or logistic regression was used to evaluate the independent association of serum phosphate with 1-year all-cause mortality, recurrent stroke, composite end point and poor functional outcome.Results: The mean age of the included 7,353 patients was 62.5 years, and 68.6% of them were men. Plotting hazard ratios over phosphate levels suggested a U-shaped association especially for recurrent stroke and composite end point, and therefore the third quartile group was set as reference group. Compared with the third quartile of phosphate (1.06–1.20 mmol/L), the adjusted hazard ratios/odds ratios (95% CI) of the lowest quartile (
- Published
- 2021
- Full Text
- View/download PDF